Letter by Shroff and Orlandi regarding article, "Randomized trial of atorvastatin for reduction of postoperative atrial fibrillation in patients undergoing cardiac surgery: results of the ARMYDA-3 (Atorvastatin for Reduction of Myocardial Dysrhythmia After Cardiac Surgery) study".

To the Editor: We read with great interest the study by Patti and colleagues1 that suggests a beneficial effect of atorvastatin in preventing postoperative atrial fibrillation in cardiac surgery patients. The placebo arm in this study had fewer patients on β-blockers (60% versus 72%, P =0.08), more patients with left atrial …